Head James M
Head James M's purchase track record
Head James M has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/29/2021 | CTEV | $1.30M | -12.2% | +16.8% | -11.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Claritev Selected by GDIT for WTC Health Program Support. Claritev has been selected by General Dynamics Information Technology (GDIT) to support the World Trade Center Health Program. The financial terms of this agreement were not disclosed. This development adds a notable government-related contract to the company's portfolio, which is relevant context given the stock is currently trading near its 52-week low.
Transaction History
| ALHC | ▼ Sell | Open Market | 11,100 | $234K | 4/7/2026 | View on chart |
| ALHC | ▲ Buy | Grant | 103,002 | $0 | 3/13/2026 | View on chart |
| ALHC | ▲ Buy | Grant | 81,593 | $0 | 6/4/2025 | View on chart |
| CTEV | ▼ Sell | Tax Withholding | 226,997 | $252K | 3/1/2024 | View on chart |
| CTEV | ▲ Buy | Grant | 1,387,388 | $1.5M | 3/1/2024 | View on chart |
| CTEV | ▲ Buy | Grant | 2,222,222 | $0 | 3/1/2023 | View on chart |
| CTEV | ▲ Buy | Open Market | 300,000 | $1.3M | 11/29/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
ALHC Faces Downgrade and Lower Target Amid Mixed CMS Ratings
Alignment Healthcare shares are trading lower after William Blair downgraded the stock to Market Perform and JP Morgan cut its price target to $10. These moves followed mixed California Star Ratings and news of network expansion, which analysts say highlight ongoing operational challenges. The stock is currently trading near its 52-week low, reflecting the negative sentiment from these recent analyst actions.
ALHC Faces Downgrade and Lower Target Amid Mixed CMS Ratings. Alignment Healthcare shares are trading lower after William Blair downgraded the stock to Market Perform and JP Morgan cut its price target to $10. These moves followed mixed California Star Ratings and news of network expansion, which analysts say highlight ongoing operational challenges. The stock is currently trading near its 52-week low, reflecting the negative sentiment from these recent analyst actions.